Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
Public ClinicalTrials.gov record NCT00857415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Study of the Correlation Between Florbetapir F 18 (18F-AV-45) PET Imaging and Amyloid Pathology
Study identification
- NCT ID
- NCT00857415
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Avid Radiopharmaceuticals
- Industry
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Interventions
- florbetapir F 18 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Feb 28, 2010
- Completion
- Apr 30, 2010
- Last update posted
- May 21, 2012
2008 – 2010
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Sun City | Arizona | 85351 | — |
| Research Site | Little Rock | Arkansas | 72211 | — |
| Research Site | Irvine | California | 92697 | — |
| Research Site | San Francisco | California | 94109 | — |
| Research Site | Fort Myers | Florida | 33912 | — |
| Research Site | Miami | Florida | 33137 | — |
| Research Site | Miami Beach | Florida | 33140 | — |
| Research Site | Miami Springs | Florida | 33166 | — |
| Research Site | Orlando | Florida | 32835 | — |
| Research Site | Sarasota | Florida | 34231 | — |
| Research Site | St. Petersburg | Florida | 33709 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Baltimore | Maryland | 21221 | — |
| Research Site | Hattiesburg | Mississippi | 39401 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Albany | New York | 12208 | — |
| Research Site | New Hyde Park | New York | 11040 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Centerville | Ohio | 45459 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Charleston | South Carolina | 29425 | — |
| Research Site | Johnson City | Tennessee | 37614 | — |
| Research Site | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00857415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2012 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00857415 live on ClinicalTrials.gov.